Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberCN1688582 A
Publication typeApplication
Application numberCN 03823367
PCT numberPCT/EP2003/010377
Publication date26 Oct 2005
Filing date18 Sep 2003
Priority date30 Sep 2002
Also published asCA2499134A1, CA2499134C, CN100384846C, DE60324296D1, EP1549652A1, EP1549652B1, EP2042504A1, EP2042504B1, US7511041, US8129386, US20060128732, US20090270388, WO2004029055A1
Publication number03823367.3, CN 03823367, CN 1688582 A, CN 1688582A, CN-A-1688582, CN03823367, CN03823367.3, CN1688582 A, CN1688582A, PCT/2003/10377, PCT/EP/2003/010377, PCT/EP/2003/10377, PCT/EP/3/010377, PCT/EP/3/10377, PCT/EP2003/010377, PCT/EP2003/10377, PCT/EP2003010377, PCT/EP200310377, PCT/EP3/010377, PCT/EP3/10377, PCT/EP3010377, PCT/EP310377
InventorsM施马达, T穆拉塔, K富基卡米, H楚吉施塔, N奥莫里, I卡托, M缪拉, K乌尔巴恩斯, F甘特纳, K巴康
Applicant拜尔药品公司
Export CitationBiBTeX, EndNote, RefMan
External Links: SIPO, Espacenet
稠合吡咯-嘧啶衍生物
CN 1688582 A
Description  available in Chinese
Claims(26)  available in Chinese
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
CN102459253A *28 Apr 201016 May 2012葛兰素集团有限公司作为pi3-激酶抑制剂的*唑取代的吲唑化合物
CN102459253B *28 Apr 201025 Mar 2015葛兰素集团有限公司作为pi3-激酶抑制剂的*唑取代的吲唑化合物
CN103339133A *8 Nov 20112 Oct 2013拜耳知识产权有限责任公司烷氧基取代的2,3-二氢咪唑并[1,2-c]喹唑啉
CN103339133B *8 Nov 201115 Jun 2016拜耳知识产权有限责任公司烷氧基取代的2,3-二氢咪唑并[1,2-c]喹唑啉
CN103370320A *8 Nov 201123 Oct 2013拜耳知识产权有限责任公司芳基氨基醇取代的2,3-二氢咪唑并[1,2-c]喹啉
CN103370320B *8 Nov 201127 Apr 2016拜耳知识产权有限责任公司芳基氨基醇取代的2,3-二氢咪唑并[1,2-c]喹啉
CN103649091A *29 Mar 201219 Mar 2014拜耳知识产权有限责任公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉盐
CN103649091B *29 Mar 201222 Jun 2016拜耳知识产权有限责任公司取代的2,3-二氢咪唑并[1,2-c]喹唑啉盐
CN105130997A *25 Sep 20159 Dec 2015苏州明锐医药科技有限公司一种库潘尼西的制备方法
WO2017049983A1 *1 Jul 201630 Mar 2017苏州立新制药有限公司库潘尼西的制备方法
Classifications
International ClassificationC07D471/14, C07D487/04, A61P29/00, C07D519/00, C07D487/06
Cooperative ClassificationC07D471/14, C07D487/04
European ClassificationC07D487/04, C07D471/14
Legal Events
DateCodeEventDescription
26 Oct 2005C06Publication
21 Dec 2005C10Request of examination as to substance
28 Jul 2006REGReference to a national code
Ref country code: HK
Ref legal event code: DE
Ref document number: 1084393
Country of ref document: HK
30 Apr 2008C14Granted
27 Mar 2009REGReference to a national code
Ref country code: HK
Ref legal event code: GR
Ref document number: 1084393
Country of ref document: HK
26 May 2010ASSSuccession or assignment of patent right
Free format text: FORMER OWNER: BAYER PHARMACEUTICAL CO., LTD.
Effective date: 20100420
Owner name: BAYER SCHERING PHARMACEUTICAL CO., LTD.
26 May 2010C41Transfer of the right of patent application or the patent right
26 May 2010CORBibliographic change or correction in the description
Free format text: CORRECT: ADDRESS; FROM: CONNECTICUT STATE, U.S.A TO: BERLIN, GERMANY
10 Apr 2013C56Change in the name or address of the patentee
Owner name: BAYER PHARMACEUTICALS AG
Free format text: FORMER NAME: BAYER SCHERING PHARMA AG
10 Apr 2013C41Transfer of the right of patent application or the patent right
10 Apr 2013ASSSuccession or assignment of patent right
Free format text: FORMER OWNER: BAYER PHARMACEUTICALS AG
Owner name: BAYER INTELLECTUAL PROPERTY GMBH
Effective date: 20130322